Oravig available for oropharyngeal candidiasis

ORAVIG (miconazole) 50mg buccal tablets by Strativa
ORAVIG (miconazole) 50mg buccal tablets by Strativa
Strativa has made available Oravig (miconazole buccal tablets) for the treatment of oropharyngeal candidiasis (OPC) in patients ≥16 years of age. Oravig adheres to the gum and delivers miconazole directly at the local site of infection throughout the day with minimal systemic absorption.

Oravig is available as a 50mg buccal tablet.

For more information call (201) 802-4000 or visit www.oravig.com.